Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03379493
Title Study of ET190L1-ARTEMIS T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma
Recruitment Terminated
Gender
Phase Phase I
Variant Requirements No
Sponsors Eureka Therapeutics Inc.
Indications

diffuse large B-cell lymphoma

follicular lymphoma

Burkitt lymphoma

mantle cell lymphoma

non-Hodgkin lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field